Those suffering from anxiety or Tourette syndrome in Pennsylvania may have something to hope for.

Pennsylvania’s state Medical Marijuana Advisory Board on Friday voted to add anxiety and Tourette syndrome as conditions to a list that qualifies patients to buy medicinal cannabis at dispensaries across the state.

It is health Secretary Dr. Rachel Levine who has final say over whether anxiety and Tourette will officially be included to the list of qualifying conditions however.

Levine said she would review additional research before making her decision.
“Now, I’m looking beyond the applications,” she said. “I’ll be reviewing the medical literature very carefully before making my decision about these conditions.”

The board also voted to recommend that state legislators amend the Medical Marijuana Act of 2016 to add edibles as a permitted form of medical marijuana. The stipulation is that the permission comes with strict regulations related to labeling and packaging.

Patients must register with the state Department of Health and get an approved practitioner to certify they have a qualifying condition before obtaining a medical marijuana ID card.

About 112,000 patients have registered with Pennsylvania’s medical marijuana program, and 80,000 have been issued ID cards, according to John Collins, director of the Office of Medical Marijuana.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Senate Committee Passes Amendment to Loosen Restrictions for Applicants With Cannabis History
24 June 2022
Dave East on His Cannabis Company East Co. and His Love of OG Kush
17 March 2022
Montana Prepares for 2022 Launch of Adult-use Marijuana Market
21 December 2021